Literature DB >> 16148530

Gastrointestinal parasites in the immunocompromised.

Penny Lewthwaite1, Geoffrey V Gill, C Anthony Hart, Nicholas J Beeching.   

Abstract

PURPOSE OF REVIEW: Parasites and other infections have many effects on the gastrointestinal tract of individuals who are immunocompromised. Few reviews focus on parasitic infections, which are covered here. RECENT
FINDINGS: The review first examines recent advances in our understanding of the taxonomy, diagnosis and treatment of pathogens such as cryptosporidia, cyclospora, isospora and microsporidia, which are recognized causes of diarrhoea in the immunocompromised, and discusses possible links between amoebiasis and HIV. The complex interactions of both intact and abnormal immune systems with helminth infections such as hookworm and strongyloidiasis, and with trematode infections such as schistosomiasis, are receiving increasing attention. These are discussed, together with the novel concept of using live helminths to treat inflammatory bowel disease.
SUMMARY: Parasitic infections remain a significant problem for immunocompromised individuals in resource-poor settings, and further work is needed to develop accessible diagnostic tests and to improve our understanding and management of their pathogenic effects. New concepts about the interactions of helminths with host immunity suggest the need for collection of further epidemiological and clinical data to unravel the complexities of such immunological interactions.

Entities:  

Mesh:

Year:  2005        PMID: 16148530     DOI: 10.1097/01.qco.0000182104.40128.18

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  20 in total

Review 1.  Microsporidiosis: current status.

Authors:  Elizabeth S Didier; Louis M Weiss
Journal:  Curr Opin Infect Dis       Date:  2006-10       Impact factor: 4.915

2.  Coinfection with Hymenolepis nana, Hymenolepis diminuta, Giardia intestinalis, and Human Immunodeficiency Virus: A Case Report with Complex Immunologic Interactions.

Authors:  Gladymar Pérez-Chacón; Leonor A Pocaterra; Elsy Rojas; Aurora Hernán; Juan Carlos Jiménez; Luz Núñez
Journal:  Am J Trop Med Hyg       Date:  2017-05-13       Impact factor: 2.345

Review 3.  Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.

Authors:  Jaco J Verweij; C Rune Stensvold
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 4.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

5.  Prevalence of Intestinal Parasites among Immunocompromised Patients, Children, and Adults in Sana'a, Yemen.

Authors:  Asma Al-Yousofi; Yongmin Yan; Abdulsalam M Al Mekhlafi; Kamal Hezam; Fatma A Abouelnazar; Balqees Al-Rateb; Hafsah Almamary; Rasheed Abdulwase
Journal:  J Trop Med       Date:  2022-06-08

Review 6.  Advances in sexually transmitted infections of the gastrointestinal tract.

Authors:  Siew C Ng; Brian Gazzard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-25       Impact factor: 46.802

Review 7.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

8.  Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain.

Authors:  Fernando Salvador; Israel Molina; Elena Sulleiro; Joaquín Burgos; Adrián Curran; Eva Van den Eynde; Sara Villar del Saz; Jordi Navarro; Manuel Crespo; Inma Ocaña; Esteve Ribera; Vicenç Falcó; Albert Pahissa
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

9.  Gastrointestinal neoplasia associated with bowel parasitosis: real or imaginary?

Authors:  Michael R Peterson; Noel Weidner
Journal:  J Trop Med       Date:  2011-11-30

10.  Clinical use of anti-TNF therapy and increased risk of infections.

Authors:  Tauseef Ali; Sindhu Kaitha; Sultan Mahmood; Abdul Ftesi; Jordan Stone; Michael S Bronze
Journal:  Drug Healthc Patient Saf       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.